New Lancet Phase III Study Shows Proton Therapy Significantly Improves Survival and Reduces Toxicity in Head and Neck Cancers - Marking a Breakthrough in Advanced Cancer Care

Media seeking NAPT materials can access assets here.
Denton Record-Chronicle

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates

Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more ...
The Healthy @Reader's Digest

20-Year Study: Doing This One Thing After Age 65 Can Add 4 or More Years to Your Life

Picking up a healthy new habit could extend your life—plus, three other factors that could help (or hurt) your longevity odds ...

Landmark Global Study on Ovarian Cancer Published in The Lancet Obstetrics, Gynaecology, & Women's Health

The World Ovarian Cancer Coalition announced that a groundbreaking international study, "Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Wo ...
STAT

New antibiotic can effectively treat gonorrhea, study finds

A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating ...

Prediabetes remission may cut heart attack and early death risk by 50 per cent, says Lancet report

Bringing blood sugar back to normal through lifestyle changes could cut the risk of heart attack, heart failure and early ...
Yahoo Finance

Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates

Results showed Brainomix 360 Stroke was associated with a 100% increase in endovascular thrombectomy rates, with a particularly significant impact on treatment rates in primary stroke centers, and a ...